Trials / Completed
CompletedNCT04389645
Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- MeMed Diagnostics Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The proposed project will pilot incorporation of rapid serial measurements of IP-10 into a CDS tool for moderate and severe COVID-19 patients. The tool was applied to all comers with confirmed COVID-19 diagnosis at a secondary medical center in Israel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | IP-10 in CDS protocol | Dynamic IP-10 measurements in hospitalized COVID-19 positive patients |
Timeline
- Start date
- 2020-04-07
- Primary completion
- 2020-05-12
- Completion
- 2020-05-12
- First posted
- 2020-05-15
- Last updated
- 2020-05-15
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04389645. Inclusion in this directory is not an endorsement.